# FDA 483 - Mehrnaz Hojjati MD - August 26, 2021

Source: https://www.globalkeysolutions.net/records/483/mehrnaz-hojjati-md/12d21e05-8301-43da-ba82-6c7e2a2793c3

> FDA 483 for Mehrnaz Hojjati MD on August 26, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mehrnaz Hojjati MD
- Inspection Date: 2021-08-26
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Mehrnaz Hojjati MD in Loma Linda, CA, a clinical investigator, revealed significant deviations from the investigational plan and protocol. The firm enrolled subjects using an expired protocol and failed to ensure subjects received all required tests. Additionally, protocol deviations were not reported in a timely manner.

## Related Documents

- [EIR - 2021-08-26](https://www.globalkeysolutions.net/records/eir/mehrnaz-hojjati-md/feff39fe-3557-4497-8a22-4548d1ced1cc)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/humberto-z-gomez/6de682f6-ae2a-45ff-92ab-ba6ac7bb97b4)

Company: https://www.globalkeysolutions.net/companies/mehrnaz-hojjati-md/675abc7c-b3a9-4247-8acd-0f3aa1a04ce8

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6